ROP
65
2
MRO
43
-3
EQT
60
-2
GT
62
-3
BIIB
28
-3
ETN
83
-3
TRIP
54
-3
LYB
37
-2
PDCO
36
-2
MSFT
57
4
AIZ
75
2
AEE
63
-3
RIG
46
-8
EW
29
-3
TAP
60
2
BAX
27
-2
UPS
41
-2
BLK
72
-4
EMN
52
-3
LUV
47
-2
ROP
65
2
MRO
43
-3
EQT
60
-2
GT
62
-3
BIIB
28
-3
ETN
83
-3
TRIP
54
-3
LYB
37
-2
PDCO
36
-2
MSFT
57
4
AIZ
75
2
AEE
63
-3
RIG
46
-8
EW
29
-3
TAP
60
2
BAX
27
-2
UPS
41
-2
BLK
72
-4
EMN
52
-3
LUV
47
-2
Financhill
Back

Arbutus Biopharma Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Sell
40

ABUS
Arbutus Biopharma

Last Price:
3.66
Seasonality Move:
13.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Arbutus Biopharma Price Quote

$3.66
+0.01 (+0.27%)
(Updated: November 13, 2024 at 5:55 PM ET)

Arbutus Biopharma Key Stats

Sell
40
Arbutus Biopharma (ABUS) is a Sell
Day range:
$3.61 - $3.75
52-week range:
$1.75 - $4.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
97.62
P/B ratio:
6.47%
Volume:
777.7K
Avg. volume:
827.9K
1-year change:
106.21%
Market cap:
$691.6M
Revenue:
$18.1M
EPS:
$-0.43

How Much Does Arbutus Biopharma Make?

Is Arbutus Biopharma Growing As A Company?

  • What Is Arbutus Biopharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.71%
  • What Is Arbutus Biopharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Arbutus Biopharma Stock Price Performance

  • Did Arbutus Biopharma Stock Go Up Last Month?
    Arbutus Biopharma share price went down by -5.93% last month
  • Did ABUS's Share Price Rise Over The Last Year?
    ABUS share price rose by 106.21% over the past 1 year

What Is Arbutus Biopharma 52-Week High & Low?

Arbutus Biopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arbutus Biopharma?

  • How Much Debt Does Arbutus Biopharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Arbutus Biopharma Have?
    Cash and short term investments quarterly total is $127.8M
  • What Is Arbutus Biopharma’s Book Value Per Share?
    Book value per share is 0.56

Is Arbutus Biopharma Cash Flow Positive?

  • What Is ABUS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$71.8M
  • What Is Arbutus Biopharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $54.4M
  • What Is Arbutus Biopharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $31.8M

Arbutus Biopharma Return On Invested Capital

  • Is Management Doing A Good Job?
    ABUS return on invested capital is -67.36%
  • What Is Arbutus Biopharma Return On Assets?
    ROA measures how assets are converting to revenues and is -50.88%
  • What Is ABUS Return On Equity?
    ROE is a measure of profitability and is -67.36%

Arbutus Biopharma Earnings Date & Stock Price

Arbutus Biopharma Competitors

  • Who Are Arbutus Biopharma's Competitors?
    Below is a list of companies who compete with Arbutus Biopharma or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • FibroGen Inc (FGEN)
    • Amicus Therapeutics Inc (FOLD)
    • GlycoMimetics Inc (GLYC)
    • Ionis Pharmaceuticals Inc (IONS)

Arbutus Biopharma Dividend Yield

Arbutus Biopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.95%
Revenue: -71.25% -28.55%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 5.09
Upside from Last Price: 39.47%

Major Shareholders

  • How many ABUS shares are owned by institutional investors?
    161.9M ABUS shares are owned by institutional investors
  • How many ABUS shares are owned by insiders?
    6.8M ABUS shares are owned by insiders